Skip Navigation



Carcinogenesis Advance Access published online on April 9, 2009

Carcinogenesis, doi:10.1093/carcin/bgp085
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow All Versions of this Article:
30/7/1089    most recent
bgp085v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Provençal, M.
Right arrow Articles by Béliveau, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Provençal, M.
Right arrow Articles by Béliveau, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

C-Met Activation In Medulloblastoma Induces Tissue Factor Expression And Activity: Effects On Cell Migration*

Mathieu Provençal1, David Labbé1, Ryan Veitch1, Dominique Boivin1, Georges-Étienne Rivard2, Hervé Sartelet3, Yves Robitaille3, Denis Gingras1 and Richard Béliveau1,2

1 Laboratoire de médecine moléculaire, Université du Québec à Montréal, C.P. 8888, Succ. Centre-ville, Montréal, Québec H3C 3P8
2 Service d'Hématologie-Oncologie
3 Département de Pathologie, Hôpital Ste-Justine, 3175, Chemin Côte-Sainte-Catherine, Montréal, Québec (Canada) H3T 1C5

To whom correspondence should be addressed : Laboratoire de médecine moléculaire, Université du Québec à Montréal, C.P. 8888, Succ. Centre-ville, Montréal, Québec H3C 3P8, Phone: (514) 987-3000 x8551, FAX: (514) 987-0246, E-mail: oncomol{at}nobel.si.uqam.ca

Met, the receptor for hepatocyte growth factor (HGF), is a receptor tyrosine kinase that has recently emerged as an important contributor to human neoplasia. In physiological and pathological conditions, Met triggers various cellular functions related to cell proliferation, cell migration and the inhibition of apoptosis, and also regulates a genetic program leading to coagulation. Since medulloblastomas (MB) express high levels of tissue factor (TF), the main initiator of blood coagulation, we therefore examined the link between Met and TF expression in these pediatric tumors. We observed that stimulation of the medulloblastoma cell line DAOY with HGF led to a marked increase of TF expression and procoagulant activity, in agreement with analysis of clinical MB tumor specimens, in which tumors expressing high levels of Met also showed high levels of TF. The HGF-dependent increase in TF expression and activity required Src family kinases and led to the translocation of TF to actin-rich structures at the cell periphery, suggesting a role of the protein in cell migration. Accordingly, addition of physiological concentrations of the TF activator FVIIa to HGF-stimulated DAOY cells promoted a marked increase in the migratory potential of these cells. Overall, these results suggest that HGF-induced activation of the Met receptor results in TF expression by MB cells and that this event likely contribute to tumor proliferation by enabling the formation of a provisional fibrin matrix. In addition, TF-mediated non-haemostatic functions, such as migration towards FVIIa, may also play a central role in MB aggressiveness.

Key Words: Medulloblastoma • MET • Tissue factor • Hepatocyte growth factor


* This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC).

Received November 17, 2008; revised March 25, 2009; accepted April 4, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Milsom, N. Magnus, B. Meehan, K. Al-Nedawi, D. Garnier, and J. Rak
Tissue Factor and Cancer Stem Cells: Is There a Linkage?
Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2005 - 2014.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.